Skip to content

Remecare

Active
Boomsesteenweg 46 ·2630 Aartselaar, Belgium
BE 0774.519.660
Watch Print / PDF
Age4 yrs
Staff (FTE)3.8

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Remecare is 0.6% (low). The 2024 annual accounts show negative equity (€-2.77M) and a net result of €-1.13M. Equity is shrinking by ~66.9% per year across the filed fiscal years. Its solvency ranks better than 9% of 96 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.6% Low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Trust signals

3 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-1.13M-7.2%
Working capital€158k

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 30-08-2025 with the NBB · fiscal year 2024 · verkort
€-1.50M€-1.00M€-500k€0Operating result 2022: €-573k€-573kNet result 2022: €-600k€-600kOperating result 2023: €-1.02M€-1.02MNet result 2023: €-1.06M€-1.06MOperating result 2024: €-1.08M€-1.08MNet result 2024: €-1.13M€-1.13M202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining Equity: declining trend of ~66.9%/year over 3 fiscal years, indicative, assuming unchanged policy.
€-8.00M€-6.00M€-4.00M€-2.00M€02025: €-3.87M (€-4.09M - €-3.65M)2026: €-4.97M (€-5.19M - €-4.74M)2027: €-6.06M (€-6.28M - €-5.84M)2022: €-580k2023: €-1.64M2024: €-2.77M202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 26 · compared across all schema types (micro, abbreviated and full combined)
Metric This company Sector median Position in the sector
Solvency -80.1% 38.1%
better than 9% of 96 sector peers
Net result €-1.13M €10k
better than 5% of 96 sector peers
Equity €-2.77M €43k
better than 5% of 96 sector peers
Gross operating margin €-12k €38k
better than 16% of 92 sector peers
Staff costs €293k €100k
higher than 70% of 48 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€-306k
+28.4% far below sector median
Net profit
€-1.13M
-7.2% far below sector median
Cash flow
€-357k
+23.4% far below sector median
Total assets
€3.46M
+6.9% +109% vs sector
Equity
€-2.77M
-69.3% far below sector median
Working capital
€158k
- -79% vs sector
Employees (FTE)
4
-20.8% +21% vs sector
Staff costs
€293k
-12.5% -36% vs sector
Income taxes
€185
-56.2% -97% vs sector
Debt
€6.24M
+27.8% far above sector median
Debt ≤ 1y
€271k
-13.7% -24% vs sector
Debt > 1y
€5.85M
+30.0% 22-24
Current ratio
1.58
+72.4% -20% vs sector
Quick ratio
1.58
+72.4% -17% vs sector
Solvency
-80.1%
-58.4% far below sector median
Debt / equity
-2.25
+24.5% far below sector median
ROE
40.9%
-36.7% far above sector median
ROA
-32.8%
-0.3% far below sector median
Interest coverage
-6.05
+46.9% far below sector median
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA€-306k
Net profit€-1.13M
Cash flow€-357k
Staff costs€293k
Income taxes€185
Dividends-
Total assets€3.46M
Equity€-2.77M
Debt€6.24M
of which ≤ 1y€271k
of which > 1y€5.85M
Working capital€158k
Employees (FTE)3.8
Ratios (computed)
2024
Current ratio1.58
Quick ratio1.58
Working capital ratio4.6%
Solvency-80.1%
Debt / equity-2.25
Long-term debt ratio-2.11
Interest coverage-6.05
Gross margin-
Net margin-
ROA-32.8%
ROE40.9%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€3.46M
Fixed assets 21/28€3.03M
Intangible fixed assets 21€2.99M
Tangible fixed assets 22/27€43k
Financial fixed assets 28€0
Current assets 29/58€429k
Amounts receivable within one year 40/41€330k
Cash & bank 54/58€98k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€3.46M
Equity 10/15€-2.77M
Contributions / capital 10/11€20k
Accumulated profits (losses) 14€-2.79M
Amounts payable 17/49€6.24M
Amounts payable after one year 17€5.85M
Amounts payable within one year 42/48€271k
Trade debts payable within one year 44€238k
Income statement
Gross operating margin 9900€-12k
Operating result 9901€-1.08M
Financial income 75€1
Financial charges 65€51k
Result before taxes 9903€-1.13M
Income taxes 67/77€185
Net result for the period 9904€-1.13M
Result to be appropriated 9905€-1.13M
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
37 / 100 Weak
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
Remecare
Boomsesteenweg 46, 2630 AartselaarVervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur
since 20212.321.932.055
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1,894 m²
Buildings1
Building footprint193 m²
Volume (LiDAR)966 m³
Tallest building7.0 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11372A0301/00Y000 Flanders 1,894 m² 1 · 193 m² 7.0 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health37Profitability100Solvency57Growth32Stability94
64 / 100

Strong profile, led by profitability.

Health 37
Profitability 100
Solvency 57
Growth 32
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur26600Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur26600Ontwerpen en programmeren van computerprogramma's62010Ontwerpen van computerprogramma’s62100Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels47740Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen47741
Primary activity highlighted.
Names & trade names
Legal nameNL Remecare
Registered office
Boomsesteenweg 46
2630 Aartselaar, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.